What is the share price of Ortin Global Ltd (ORTINGLOBE) today?
The share price of ORTINGLOBE as on 12th May 2025 is ₹10.72. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ortin Global Ltd (ORTINGLOBE) share?
The past returns of Ortin Global Ltd (ORTINGLOBE) share are- Past 1 week: -7.84%
- Past 1 month: -4.04%
- Past 3 months: -30.43%
- Past 6 months: -44.80%
- Past 1 year: -41.26%
- Past 3 years: -50.71%
- Past 5 years: -67.02%
What are the peers or stocks similar to Ortin Global Ltd (ORTINGLOBE)?
The peers or stocks similar to Ortin Global Ltd (ORTINGLOBE) include:What is the market cap of Ortin Global Ltd (ORTINGLOBE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ortin Global Ltd (ORTINGLOBE) is ₹8.31 Cr as of 12th May 2025.What is the 52 week high and low of Ortin Global Ltd (ORTINGLOBE) share?
The 52-week high of Ortin Global Ltd (ORTINGLOBE) is ₹24.82 and the 52-week low is ₹9.64.What is the PE and PB ratio of Ortin Global Ltd (ORTINGLOBE) stock?
The P/E (price-to-earnings) ratio of Ortin Global Ltd (ORTINGLOBE) is -1.03. The P/B (price-to-book) ratio is 2.95.Which sector does Ortin Global Ltd (ORTINGLOBE) belong to?
Ortin Global Ltd (ORTINGLOBE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ortin Global Ltd (ORTINGLOBE) shares?
You can directly buy Ortin Global Ltd (ORTINGLOBE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ortin Global Ltd
ORTINGLOBE Share Price
ORTINGLOBE Share Price Chart
How to use scorecard? Learn more
ORTINGLOBE Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-1.72 | 2.95 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
48.25 | 6.28 | 0.53% |
ORTINGLOBE Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
ORTINGLOBE Company Profile
Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.
ORTINGLOBE Similar Stocks (Peers)
Compare with peersORTINGLOBE Forecasts
Price
Revenue
Earnings
ORTINGLOBE Share Price Forecast
ORTINGLOBE Company Revenue Forecast
ORTINGLOBE Stock EPS (Earnings Per Share) Forecast
ORTINGLOBE
Income
Balance Sheet
Cash Flow
ORTINGLOBE Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 63.52 | 62.20 | 80.16 | 167.89 | 197.58 | 8.22 | 8.42 | 6.06 | 2.28 | 0.62 | ||||||||||
Raw Materials | 45.08 | 38.48 | 56.30 | 141.54 | 165.15 | 4.08 | 4.61 | 3.89 | 2.38 | 4.34 | ||||||||||
Power & Fuel Cost | 4.68 | 4.75 | 4.10 | 5.67 | 5.39 | 0.11 | 0.22 | 0.24 | 0.17 | |||||||||||
Employee Cost | 2.13 | 2.59 | 2.78 | 3.68 | 4.72 | 0.85 | 0.74 | 0.68 | 0.48 | |||||||||||
Selling & Administrative Expenses | 3.30 | 2.53 | 2.23 | 3.42 | 4.71 | 1.06 | 1.42 | 0.72 | 1.31 | |||||||||||
Operating & Other expenses | 1.87 | 8.08 | 8.91 | 6.77 | 11.73 | 0.82 | 0.87 | 0.00 | 4.30 | |||||||||||
EBITDA | 6.46 | 5.77 | 5.84 | 6.81 | 5.88 | 1.30 | 0.56 | 0.53 | -6.36 | -3.72 | ||||||||||
Depreciation/Amortization | 1.65 | 1.70 | 1.69 | 1.75 | 1.96 | 0.29 | 0.29 | 0.25 | 0.23 | 0.05 | ||||||||||
PBIT | 4.81 | 4.07 | 4.15 | 5.06 | 3.92 | 1.01 | 0.27 | 0.28 | -6.59 | -3.77 | ||||||||||
Interest & Other Items | 3.42 | 2.94 | 3.49 | 3.22 | 3.21 | 0.87 | 0.81 | 0.40 | 0.48 | 0.09 | ||||||||||
PBT | 1.39 | 1.13 | 0.66 | 1.84 | 0.71 | 0.14 | -0.54 | -0.12 | -7.07 | -3.86 | ||||||||||
Taxes & Other Items | 0.57 | 0.63 | 0.00 | 0.56 | 1.29 | -0.81 | -0.13 | -0.02 | 0.96 | 0.97 | ||||||||||
Net Income | 0.82 | 0.50 | 0.66 | 1.28 | -0.58 | 0.95 | -0.41 | -0.10 | -8.03 | -4.83 | ||||||||||
EPS | 0.48 | 0.30 | 0.39 | 0.76 | -0.34 | 0.76 | -0.50 | -0.12 | -9.88 | -5.94 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ORTINGLOBE Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFORTINGLOBE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ortin Global Ltd | -1.03 | 2.95 | — |
Sun Pharmaceutical Industries Ltd | 43.72 | 6.24 | 0.77% |
Cipla Ltd | 29.00 | 4.46 | 0.88% |
Torrent Pharmaceuticals Ltd | 64.18 | 15.51 | 0.89% |
ORTINGLOBE Stock Price Comparison
Compare ORTINGLOBE with any stock or ETFORTINGLOBE Shareholdings
ORTINGLOBE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ORTINGLOBE Institutional Holdings Trend
In last 3 months, retail holding in the company has increased by 1.01%
In last 3 months, foreign institutional holding of the company has almost stayed constant
ORTINGLOBE Shareholding Pattern
ORTINGLOBE Shareholding History
smallcases containing ORTINGLOBE stock
Looks like this stock is not in any smallcase yet.
ORTINGLOBE Events
ORTINGLOBE Dividend Trend
ORTINGLOBE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
ORTINGLOBE Upcoming Dividends
No upcoming dividends are available
ORTINGLOBE Past Dividends
Cash Dividend
Ex DateEx DateSep 24, 2013
Dividend/Share
₹0.25
Ex DateEx Date
Sep 24, 2013
Cash Dividend
Ex DateEx DateSep 24, 2012
Dividend/Share
₹0.50
Ex DateEx Date
Sep 24, 2012
Cash Dividend
Ex DateEx DateOct 13, 2011
Dividend/Share
₹0.50
Ex DateEx Date
Oct 13, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Dividend/Share
₹0.80
Ex DateEx Date
Sep 23, 2010
ORTINGLOBE Stock News & Opinions
Net Loss of Ortin Global reported to Rs 0.11 crore in the quarter ended December 2024 as against net loss of Rs 2.79 crore during the previous quarter ended December 2023. Sales declined 78.57% to Rs 0.03 crore in the quarter ended December 2024 as against Rs 0.14 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.030.14 -79 OPM %-433.33-1864.29 - PBDT-0.12-2.75 96 PBT-0.12-2.81 96 NP-0.11-2.79 96 Powered by Capital Market - Live
Ortin Global will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Net Loss of Ortin Global reported to Rs 0.47 crore in the quarter ended September 2024 as against net loss of Rs 1.12 crore during the previous quarter ended September 2023. Sales declined 80.77% to Rs 0.05 crore in the quarter ended September 2024 as against Rs 0.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.050.26 -81 OPM %-900.00-342.31 - PBDT-0.47-1.04 55 PBT-0.47-1.10 57 NP-0.47-1.12 58 Powered by Capital Market - Live
Ortin Global will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Ortin Laboratories announced that the 37th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net loss of Ortin Laboratories reported to Rs 0.10 crore in the quarter ended June 2024 as against net profit of Rs 0.02 crore during the previous quarter ended June 2023. Sales declined 86.62% to Rs 0.21 crore in the quarter ended June 2024 as against Rs 1.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.211.57 -87 OPM %-47.6212.10 - PBDT-0.100.08 PL PBT-0.100.02 PL NP-0.100.02 PL Powered by Capital Market - Live
Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 31 July 2024.Powered by Capital Market - Live
Ortin Laboratories reports standalone net profit of Rs 0.46 crore in the December 2022 quarter

Ortin Laboratories Ltd leads gainers in ‘B’ group

Over the last 5 years, revenue has grown at a yearly rate of -57.68%, vs industry avg of 9.04%
Over the last 5 years, market share decreased from 0.08% to 0%